Webcam Delivery of the Camperdown Program for Adolescents Who Stutter: A Phase II Trial

被引:38
作者
Carey, Brenda [1 ]
O'Brian, Sue [1 ]
Lowe, Robyn [1 ]
Onslow, Mark [1 ]
机构
[1] Univ Sydney, Australian Stuttering Res Ctr, Sydney, NSW 2006, Australia
关键词
stuttering; adolescents; Camperdown Program; telehealth; LONG-TERM; CLINICAL-TRIAL; SPEECH; ADULTS; SEVERITY; CHILDREN; RELIABILITY; STEREOTYPES; ATTITUDES; THERAPY;
D O I
10.1044/2014_LSHSS-13-0067
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Purpose: This Phase II clinical trial examined stuttering adolescents' responsiveness to the Webcam-delivered Camperdown Program. Method: Sixteen adolescents were treated by Webcam with no clinic attendance. Primary outcome was percentage of syllables stuttered (%SS). Secondary outcomes were number of sessions, weeks and hours to maintenance, self-reported stuttering severity, speech satisfaction, speech naturalness, self-reported anxiety, self-reported situation avoidance, self-reported impact of stuttering, and satisfaction with Webcam treatment delivery. Data were collected before treatment and up to 12 months after entry into maintenance. Results: Fourteen participants completed the treatment. Group mean stuttering frequency was 6.1 %SS (range, 0.7-14.7) pretreatment and 2.8 %SS (range, 0-12.2) 12 months after entry into maintenance, with half the participants stuttering at 1.2 %SS or lower at this time. Treatment was completed in a mean of 25 sessions (15.5 hr). Self-reported stuttering severity ratings, self-reported stuttering impact, and speech satisfaction scores supported %SS outcomes. Minimal anxiety was evident either pre- or post-treatment. Individual responsiveness to the treatment varied, with half the participants showing little reduction in avoidance of speech situations. Conclusions: The Webcam service delivery model was appealing to participants, although it was efficacious and efficient for only half. Suggestions for future stuttering treatment development for adolescents are discussed.
引用
收藏
页码:314 / 324
页数:11
相关论文
共 50 条
  • [41] Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
    Ghosn, Mario
    Cheema, Waseem
    Zhu, Amy
    Livschitz, Jennifer
    Maybody, Majid
    Boas, Franz E.
    Santos, Ernesto
    Kim, DaeHee
    Beattie, Jason A.
    Offin, Michael
    Rusch, Valerie W.
    Zauderer, Marjorie G.
    Adusumilli, Prasad S.
    Solomon, Stephen B.
    LUNG CANCER, 2022, 165 : 1 - 9
  • [42] The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial
    Ripamonti, Carla Ida
    Prandi, Cesarina
    Costantini, Massimo
    Perfetti, Elisa
    Pellegrini, Fabio
    Visentin, Marco
    Garrino, Lorenza
    De Luca, Anna
    Pessi, Maria Adelaide
    Peruselli, Carlo
    BMC PALLIATIVE CARE, 2014, 13
  • [43] A double-blind phase II randomized controlled trial of an online cognitive bias modification for interpretation program with and without psychoeducation for people with chronic pain
    Sharpe, Louise
    Jones, Emma Blaisdale
    Pradhan, Poorva
    Todd, Jemma
    Colagiuri, Ben
    PAIN, 2023, 164 (04) : E217 - E227
  • [44] HAPPi Kneecaps! A double-blind, randomised, parallel group superiority trial investigating the effects of sHoe inserts for adolescents with patellofemoral PaIn: phase II feasibility study
    Isobel C. O’Sullivan
    Kay M. Crossley
    Steven J. Kamper
    Marienke van Middelkoop
    Bill Vicenzino
    Melinda M. Franettovich Smith
    Hylton B. Menz
    Anne J. Smith
    Kylie Tucker
    Karina T. O’Leary
    Nathalia Costa
    Natalie J. Collins
    Journal of Foot and Ankle Research, 14
  • [45] Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial
    Fu, Zhixue
    Yang, Xu
    Wang, Wenqing
    Deng, Lei
    Zhang, Tao
    Bi, Nan
    Wang, Xiaozhen
    Chen, Dongfu
    Zhou, Zongmei
    Wang, Luhua
    Liang, Jun
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [46] Trial in Progress: Phase Ib/II Study of Siremadlin in Combination With Venetoclax plus Azacitidine in Patients With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy (IC)
    Daver, Naval G.
    Wei, Andrew H.
    Stein, Eytan M.
    DeAngelo, Daniel J.
    Pathak, Dhrubajyoti
    Xu, Yunnan
    Grzesiak, Stephanie
    Venditti, Adriano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S217 - S217
  • [47] Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial
    Lee, Oukseub
    Pilewskie, Melissa
    Karlan, Scott
    Tull, Mary B.
    Benante, Kelly
    Xu, Yanfei
    Blanco, Luis
    Helenowski, Irene
    Kocherginsky, Masha
    Yadav, Shivangi
    Hosseini, Omid
    Hansen, Nora
    Bethke, Kevin
    Muzzio, Miguel
    Troester, Melissa A.
    Dimond, Eileen
    Perloff, Marjorie
    Heckman-Stoddard, Brandy
    Khan, Seema A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (03) : 728 - 738
  • [48] Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
    O'Brien, Maureen M.
    Ji, Lingyun
    Shah, Nirali N.
    Rheingold, Susan R.
    Bhojwani, Deepa
    Yuan, Constance M.
    Xu, Xinxin
    Yi, Joanna S.
    Harris, Andrew C.
    Brown, Patrick A.
    Borowitz, Michael J.
    Militano, Olga
    Kairalla, John
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Gore, Lia
    Loh, Mignon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (09) : 956 - 967
  • [49] Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group
    Rueda, Antonio
    Calvo, Virginia
    Casanova, Maria
    Rodriguez-Abreu, Delvys
    Aguiar, David
    Llanos, Marta
    Alvarez, Ruth
    Martinez-Banaclocha, Natividad
    Alfaro, Jesus
    Quero, Cristina
    Blasco, Ana
    de la Cruz Merino, Luis
    Herrero, Joaquin
    Garcia-Arroyo, Francisco R.
    Provencio, Mariano
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1576 - 1579
  • [50] National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
    Shaw, Bronwen E.
    Jimenez-Jimenez, Antonio Martin
    Burns, Linda J.
    Logan, Brent R.
    Khimani, Farhad
    Shaffer, Brian C.
    Shah, Nirav N.
    Mussetter, Alisha
    Tang, Xiao-Ying
    McCarty, John M.
    Alavi, Asif
    Farhadfar, Nosha
    Jamieson, Katarzyna
    Hardy, Nancy M.
    Choe, Hannah
    Ambinder, Richard F.
    Anasetti, Claudio
    Perales, Miguel-Angel
    Spellman, Stephen R.
    Howard, Alan
    Komanduri, Krishna, V
    Luznik, Leo
    Norkin, Maxim
    Pidala, Joseph A.
    Ratanatharathorn, Voravit
    Confer, Dennis L.
    Devine, Steven M.
    Horowitz, Mary M.
    Bolanos-Meade, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18) : 1971 - +